(Q39828194)

English

Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 September 2017

Characterization of the expression of variant and standard CD44 in prostate cancer cells: identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface (English)

1 reference

Europe PubMed Central

15 September 2017

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

B Desai

1

1 reference

Europe PubMed Central

15 September 2017

T Ma

2

1 reference

Europe PubMed Central

15 September 2017

J Zhu

3

1 reference

Europe PubMed Central

15 September 2017

M A Chellaiah

4

1 reference

Europe PubMed Central

15 September 2017

publication date

1 September 2009

1 reference

Europe PubMed Central

15 September 2017

Journal of Cellular Biochemistry

1 reference

Europe PubMed Central

15 September 2017

108

1 reference

Europe PubMed Central

15 September 2017

1

1 reference

Europe PubMed Central

15 September 2017

272-284

1 reference

Europe PubMed Central

15 September 2017

Matrix metalloproteinase activity and osteoclasts in experimental prostate cancer bone metastasis tissue

1 reference

https://api.crossref.org/works/10.1002%2FJCB.22248

21 January 2018

TSC2 loss in lymphangioleiomyomatosis cells correlated with expression of CD44v6, a molecular determinant of metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44: a multitude of isoforms with diverse functions

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Androgen receptor and invasion in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 potentiates the adherence of metastatic prostate and breast cancer cells to bone marrow endothelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44v(3,8-10) is involved in cytoskeleton-mediated tumor cell migration and matrix metalloproteinase (MMP-9) association in metastatic breast cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rho-dependent Rho Kinase Activation Increases CD44 Surface Expression and Bone Resorption in Osteoclasts

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of the CD44 transmembrane and cytoplasmic domains in co-ordinating adhesive and signalling events.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression and prognostic value of CD44 standard and variant v3 and v6 isoforms in prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 isoforms in metastatic cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin-dependent CD44v6 expression and cell adhesion in HepG2 cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The liberation of CD44.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Current status of CD44 variant isoforms as cancer diagnostic markers

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phosphorylation of CD44 in vivo requires both Ser323 and Ser325, but does not regulate membrane localization or cytoskeletal interaction in epithelial cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of alpha(v)beta(3) in prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Soluble CD44 variant 6 as a prognostic indicator in patients with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

De novo expression of CD44 in prostate carcinoma is correlated with systemic dissemination of prostate cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of osteopontin and CD44 as metastatic principles in prostate cancer cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are CD44 variant isoforms involved in human tumour progression?

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Variant exons v6 and v7 together expand the repertoire of glycosaminoglycans bound by CD44

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hyaluronan-dependent cell migration can be blocked by a CD44 cytoplasmic domain peptide containing a phosphoserine at position 325

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Matrix metalloproteinases and metastasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Distinct effects of two CD44 isoforms on tumor growth in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin: possible role in prostate cancer progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction between CD44 and hyaluronate is directly implicated in the regulation of tumor development.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship between CD44 expression and differentiation of human prostate adenocarcinomas.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin modulates prostate carcinoma invasive capacity through RGD-dependent upregulation of plasminogen activators

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44: from adhesion molecules to signalling regulators

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction between CD44 and osteopontin as a potential basis for metastasis formation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44v6: a target for antibody-based cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44 binding through the hemopexin-like domain is critical for its shedding by membrane-type 1 matrix metalloproteinase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of CD44 isoforms in human prostate tumor cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expression of matrix metalloproteinase-9 and bombesin/gastrin-releasing peptide in human prostate cancers and their lymph node metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of osteopontin in tumour progression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constitutive and induced CD44 shedding by ADAM-like proteases and membrane-type 1 matrix metalloproteinase.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Osteopontin deficiency produces osteoclast dysfunction due to reduced CD44 surface expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of CD44 standard, variant isoforms 3 and 6 and -catenin expression in local prostate cancer treated by radical prostatectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Actin polymerization modulates CD44 surface expression, MMP-9 activation, and osteoclast function.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CD44s expression in human colon carcinomas influences growth of liver metastases

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dentin matrix protein 1 enhances invasion potential of colon cancer cells by bridging matrix metalloproteinase-9 to integrins and CD44.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19582779

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/JCB.22248

1 reference

Europe PubMed Central

15 September 2017

0 references

1 reference

Europe PubMed Central

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39828194&oldid=2091050062"